Sofie Biosciences Enters Strategic Collaboration For The Production And Distribution Of FAPI Precursors
LOS ANGELES and RADEBERG, Germany, Oct. 10, 2019 /PRNewswire/ — Sofie Biosciences, Inc. (SOFIE), a Theranostics company, announced […]
SOFIE Co-Founder, President and CEO Patrick Phelps one of Biocom’s Life Science Catalyst Award Winners
From Biocom:
SAN DIEGO–Biocom, the association representing the California life science industry, today […]
SOFIE Signs Lease for East Coast Office to Better Support Customers
Dulles, VA, September 4th, 2019, – SOFIE Inc. (SOFIE), a Theranostics company, is furthing […]
SOFIE’s IP Named FAPI Wins SNMMI 2019 Image of The Year
SNMMI 2019 Image of the Year: 68Ga-FAPI-PET/CT in patients reflecting 12 different tumor entities. […]
SOFIE Breaks Ground On 30,000 Sq Ft Theranostic Center Of Excellence
TOTOWA, N.J., June 24, 2019 /PRNewswire/ — SOFIE Inc. (SOFIE), a Theranostics company headquartered in Los Angeles, CA, […]
SOFIE and University Clinic Heidelberg Sign License Agreement
SOFIE and University Clinic Heidelberg Sign License Agreement for Theranostics That Target Cancer Associated […]
SOFIE Expands Its Network By Acquiring Cyclotope Radiopharmacy From Houston Cyclotron Partners
HOUSTON, June 17, 2019 — Los Angeles-based SOFIE Inc. (SOFIE), a molecular imaging and theranostic company, […]
SOFIE is Awarded $5M from Three Major SBIR Grants
CULVER CITY, Calif., Oct. 5, 2018 — Today SOFIE, an emerging theranostics company focused on […]
Acquisition of Zevacor Pharma Complete
September 27th 2017 Culver City, CA – Sofie Biosciences, Inc., the molecular imaging company specializing […]